10/16/2026
Lilly explores ibogaine research opportunities
Pharmaceutical giant Lilly shows interest in advancing ibogaine studies.
Topic archive
pharmaceutical investment
2 stories
8/21/2026
Johnson & Johnson invests in Delix Therapeutics
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.